drugset / Trial / NCT00162591

Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl

NCT00162591 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this protocol is to study the prophylactic effect of remifentanil on bispectral index variation during a nociceptive stimuli.

Timeline

Start
2004-10
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 4 ng/ml Other

Indications

No indication recorded.